Dr. Rany Aburashed Chief Executive Officer & Founder of Neurogen Biomarking. CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking announced it is partnering with NeuroX, a venture of American ...

Neurogen Corporation (Nasdaq: NRGN) today announced that it has reduced its workforce by approximately 70 employees, as part of a restructuring to focus the Company's resources on its advancing ...

Neurogen continues to expand its research initiatives with Tasso technology to expand its use and evaluation within Neurogen’s testing model. “Making blood collection more patient-centric is key to ...

BRANFORD, Conn. -- Feb 8, 2008 - Neurogen Corporation today updated the status of its later stage clinical portfolio and announced the future focus of its research efforts. Key elements of the update ...

Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Findings from breakthrough approach to early ...

Neurogen Corp., the embattled drug developer in Branford, Conn., has entered a merger agreement in which the company will be sold to Ligand Pharmaceuticals Inc., a San Diego biotechnology firm, for an ...

Neurogen said it laid off 70 workers and is taking a charge of about $1.5 million in the first quarter of 2008 to pay severence benefits and other charges. The move is part of a restructuring to focus ...

Shares of biotech Neurogen (NASDAQ:NRGN) jumped 64% to $10.47 yesterday on news the company struck a deal with Merck (NYSE:MRK) to develop pain treatments. Under the deal, Merck will pay Neurogen a ...

Neurogen Corp. announced on Monday that veteran drug industry executive William H. Koster is the company’s new chief executive officer, immediately replacing the retiring Harry H. Penner Jr. Koster, ...

Neurogen Corp. on Tuesday announced the company lost nearly $6.4 million, or 36 cents a share, in the fourth quarter ended Dec. 31, compared to nearly $2.7 million, or 15 cents a share, for the same ...